Last reviewed · How we verify

NCT04603079

Nurse Leadership for Hospital Infection Control

Completed NA Last updated 13 May 2022
What this trial tests

NA trial testing Intervention for COVID-19 preventive protocols in Nurse's Role in 344 participants. Completed in 1 May 2021.

Timeline
1 March 2021
Primary endpoint
1 May 2021
1 May 2021

Quick facts

Lead sponsorForman Christian College, Pakistan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment344
Start date1 March 2021
Primary completion1 May 2021
Estimated completion1 May 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Forman Christian College, Pakistan

Who can join

Eligibility, female only, with Nurse's Role or Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to deliver an intervention to promote nurse leadership and decision-making in the hospital setting, by providing them with training for maintaining minimum service delivery standards for hospital infection control with respect to COVID-19; but also other infectious disease burden management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Nurse's Role

Currently open trials in the same condition.

Other Forman Christian College, Pakistan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04603079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing